A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial
                              
 
                                  Event:
                                  
                                    Heart Failure 2023
                                  
 
                                  Topic:
                                  
                                    Imaging
                                  
 
                                  Session:
                                  
                                    Chronic heart failure - imaging 1